References

1 . Halsted WS: The operative story of goiter. Johns Hopkins Hosp Rep 19:71, 1920

2. Thompson NW: The history of hyperparathyroidism. Acta Chir Scand 156:5-21, 1990.

3. Kocher T: Uber Kropfextirpation und ihre Folgen. Arch Klin Chirurgie 29:254, 1883.

4. Kaplan EL, Kadowaki MH, Schark C: Routine exposure of the recurrent laryngeal nerve is important during thyroidectomy. In Simmons RL, Udekwu AO (eds): Debates in Clinical surgery, Vol. 1, Chicago, Year Book, 1990, pp 191­206.

5. Henry JF, Audriffe J, Denizot A et al: The non-recurrent inferior laryngeal nerve: Review of 33 cases including 2 on the left side. Surgery 104:977-984, 1988

6. Thompson NW, Demers M: Exposure is not necessary to avoid the recurrent laryngeal nerve during thyroid operations. In Simmons RL, Udekwu AO (eds): Debates in Clinical Surgery, Vol. 1, Chicago, Year Book, 1990, pp. 207­219.

7. Moosman DA, DeWeese JS: The external laryngeal nerve as related to thyroidectomy. Surg Gynecol Obstet 127:1011, 1968

8. Cernea CR, Ferraz AR, Nishio S, et al: Surgical anatomy of the external branch of the superior laryngeal nerve. Head Neck 14:380-383, 1992.

9. Lennquist S, Cahlin C, Smeds S: The superior laryngeal nerve in thyroid surgery. Surgery 102:999, 1987.

10. Kaplan EL, SugimotoJ, Yang H, Fredland A: Postoperative hypoparathyroidism: Diagnosis and management. In Kaplan EL (ed): Surgery of the Thyroid and Parathyroid Glands. New York, Churchill Livingstone, 1983, pp 262-274.

11. Gilmour JR: The embryology of the parathyroid glands, the thymus and certain associated rudiments. J Pathol 45:507, 1937.

12. Taylor S: Surgery of the thyroid gland. In DeGroot LJ, Stanbury JB (eds): The Thyroid and Its Diseases. 4th ed. New York, John Wiley & Sons, 1975, pp 776-779.

13. Ezzat S, Sarti DA, Cain DR, Braunstein GD: Thyroid incidentalomas. Prevalence by palpation and ultrasonography. Arch Intern Med 154:1838-1840, 1994.

14. DeGroot LJ: Clinical features and management of radiation-associated thyroid carcinoma. In Kaplan EL (ed): Surgery of the Thyroid and Parathyroid Glands. Edinburgh, Churchill Livingstone, 1983, p 940.

15. Kaplan EL: An operative approach to the irradiated thyroid gland with possible carcinoma: Criteria technique and results. In DeGroot LJ, Frohman LA, Kaplan EL, Refetoff S (eds): Radiation Associated Carcinoma of the Thyroid. New York, Grune & Stratton, 1977, p 371.

16. Naunheim KS, Kaplan EL, Straus FH II et al: High dose external radiation to the neck and subsequent thyroid carcinoma. In Kaplan EL (ed): Surgery of the Thyroid and Parathyroid Glands. New York, Churchill Livingstone, 1983, pp 51-62.

17. Shafford EA, Kingston JE, Healy JC, et al: Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin’s disease. Br J Cancer 80:808-814, 1999.

18. Michel LA, Donckier JE: Thyroid cancer 15 years after Chernobyl. Lancet 359(9321):1947, 2002.

18a. Imaizumi M, Usa T, Tominaga T, et al: Radiation dose-response relationships for thyroid nodules and autoimmune thyroid disease in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 295:1011-1022, 2006.

18b. Boice J: Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA 295:1060-1062, 2006.

19. Blackburn DJ, Michel LA, Rociere A, et al: Occurrence of thyroid papillary carcinoma in young patients. A Chernobyl connection? J Pediatr Endocrinol Metab 14(5):503-506, 2001.

20a. Hegedus L: The thyroid nodule. New Eng J Med 351:1764-1771, 2004.

20b. Kaplan MM: Clinical evaluation and management of solitary thyroid nodules. In Braversman LE, Utrger RD (eds), Werner and Ingodr’s The Thyroid: A fundamental and clinical text. 9th ed. Philadelphia, Lippincott Williams and Wilkins, 2005, pp 996-1010.

20c. Backdahl M, Wallin G, Lowhagen T, et al: Fine needle biopsy cytology and DNA analysis. Surg Clin North Am 67:197, 1987.

20d. Castro MR, Gharib H: Continuing controversies in the management of thyroid nodules. Ann Intern Med 142:926-931, 2005.

21. Grant CS, van Heerden JA, Goellner JR: New diagnostic techniques in endocrine surgery. Probl Gen Surg 1:141-153, 1984.

22. Becker C: Hypothyroidism and atherosclerotic heart disease: Pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 6:432, 1985.

23. Klementschitsch P, Shen K-L, Kaplan EL: Reemergence of thyroidectomy as treatment for Graves’ disease. SUrg Clin North Am 59:35, 1979.

23a. Bartalena L, Marcocci C, Bogazzi F, et al: Relation between therapy for hyperthyroidism and the course of Graves’ opthalmopathy. New Eng J Med 338:73-78, 1998.

24. Lennquist S, Jortso E, Anderberg B, Smeds S: Beta-blockers compared with antithyroid drugs as preoperative treatment of hyperthyroidism: Drug tolerance, complications and postoperative thyroid function. Surgery 98:1141, 1985.

25. Sridama V, Reilly M, Kaplan EL, et al: Long-term follow up study of compensated low dose 131I therapy for Graves’ disease. New Eng J Med 311:426, 1984.

26. Clark OH: Total thyroidectomy: The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 196:361-370, 1982.

26a. Cobin RH, Gharib H, Bergman DA, et al: AACE/AAES medical/surgical guidelines for clinical practice: Management of thyroid cancer. Endocr Pract 7:203-220, 2001.

27. Attie JN: Modified neck dissection in treatment of thyroid cancer: A safe procedure. Eur J Cancer Clin Oncol 2:315-324, 1988.

28. Beierwaltes WH: Treatment of metastatic thyroid cancer with radioiodine and external radiation therapy. In Kaplan EL (ed): Surgery of the Thyroid and Parathyroid Glands. Clinical Surgery International, Vol. 4. Edinburgh, Churchill Livingstone, 1983, p 103.

28a. Pacini F, Ladenson PW, Schlumberger M, et al: Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma. J Clin Endocrinol 91:926-932, 2006.

29. Hay ID, Grant CS, Taylor WF, et al: Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 102:1088-1095, 1988.

30. Cady B, Rossi R: An expanded view of risk-group definition in differentiated thyroid carcinoma. Surgery 104:947-953, 1988.

31. Hay ID, Bergstralh EJ, Goellner JR, et al: Predicting outcome in papillary thyroid carcinoma: Development of a reliable scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114:1050-1058, 1993.

32. Hay ID, Grant CS, Bergstralh MS, et al: Unilateral lobectomy: Is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery 124:958-964, 1998.

33. Grant CS, Hay ID, Gough IR, et al: Local recurrence in papillary thyroid carcinoma. Is extent of surgical resection important? Surgery 104:954-962, 1988.

34. DeGroot LJ, Kaplan EL, McCormick M, Straus FH II: Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 71:414-424, 1990.

35. DeGroot LJ, Kaplan EL, Straus FH II, Shukla MS: Does the method of management of papillary thyroid carcinoma make a difference in outcome? World J Surg 18:123-130, 1994.

36. Mazzaferri EL, Jhiang SM: Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418-428, 1994.

37. van Heerden JA, Hay ID, Goellner JR, et al: Follicular thyroid carcinoma with capsular invasion alone: A non­threatening malignancy. Surgery 112:1130-1136, 1992.

38. Arganini M, Behar R, Wu FL, et al: Hurthle cell tumors: A twenty-five year experience. Surgery 100:1108, 1986.

39. DeGroot, LJ, Kaplan EL, McCormick M, Straus FH II: Morbidity and mortality in follicular thyroid cancer. J Clin Endocrinol Metab 80:2946-2952, 1995.

40. Schark C, Fulton N, Yashiro T, et al: The value of measurement of ras oncogenes and nuclear DNA analysis in the diagnosis of Hurthle cell tumors of the thyroid. World J Surg 16:745-752, 1992.

41. Segev DL, Saji M, Phillips GS, et al: Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hurthle cell neoplasms of the thyroid. J Clin Endocrinol Metab 83:2036-2042, 1998.

42. Mitchell G, Huddart R, Harmer C: Phase II evaluation of high dose accelerated radiotherapy for anaplastic thyroid carcinoma. Radiother Oncol 50:33-38, 1999.

43. Hill SC Jr: Chemotherapy of thyroid cancer. In Kaplan EL (ed): Surgery of the Thyroid and Parathyroid Glands. Vol. 4 In Clinical Surgery International, Edinburgh, Churchill Livingstone, 1983, p 103.

44. Tennvall J, Lundell G, Hallquist A, et al: Combined doxorubicin, hyperfractionated radiotherapy and surgery in anaplastic thyroid carcinoma. Report on two protocols. The Swedish Anaplastic Thyroid Cancer Group. Cancer 74:1348-1354, 1994.

45. Sizemore GW, van Heerden JA, Carney JA: Medullary carcinoma of the thyroid gland and the multiple endocrine neoplasia type 2 syndrome. In Kaplan EL (ed). Surgery of the Thyroid and Parathyroid Glands. Vol. 4. In: Clinical Surgery International. Churchill Livingstone, Edinburgh, 1983, p 75.

46. Hofstra RM, Landsvater RM, Ceccherini I, et al: A mutation in the RET proto oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 367:375-376, 1994.

46a. Machens A, Niccoli-Sire P, Hoegel J, et al: Early malignant progression of hereditary medullary thyroid cancer. New Eng J Med 349:1517-1525, 2003.

47. Goretzki PE, Hoppner W, Dotzenrath C, et al: Genetic and biochemical screening for endocrine disease. World J Surg 22:1202-1207, 1998.

48. Tisell LE, Jansson S: Recent results of reoperative surgery in medullary carcinoma of the thyroid. Wien Klin Wochenschr 100:347-348, 1988.

49. Skinner MA, DeBenedetti MK, Moley JF, et al: Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg 31:177-181, 1996.

50. Gharib H, McConahey WM, Tiego RD, et al: Medullary thyroid carcinoma: Clinicopathologic features and long term follow up of 65 patients treated during 1946 through 1970. Mayo Clin Proc 67:934-940, 1992.

51. Aina EN, Hisham A: The external laryngeal nerve in thyroid surgery: recognition and implication. ANZ J Surg 71:212-214, 2001.

52. Schwartz AE, Clark O, Ituarte P, LoGerfo P: Therapeutic controversy. Thyroid surgery: The choice. J Clin Endocrinol Metab, 83:1097-1105, 1998.

53. Delbridge L: Total thyroidectomy: The evolution of surgical technique. ANZ J Surg 73(9):761-768, 2003.

54. Dackiw AP, Clark OH: Bilateral thyroidectomy: Indications and technique. In: Surgery of the Thyroid and Parathyroid Glands. Randolph GW (ed), Philadelphia, WB Saunders, 19

55. Ikeda Y, Takami H, Sasaki Y, et al. Are there significant benefits of minimally invasive endoscopic thyroidectomy? World J Surg 2004; 28(11):1075-8.

56. Shimizu K, Tanaka S. Asian perspective on endoscopic thyroidectomy -- a review of 193 cases. Asian J Surg 2003; 26 (2):92-100.

57. Takami HE, Ikeda Y. Minimally invasive thyroidectomy. Curr Opin Oncol 2006; 18(1):43-7.

58. Miccoli P, Berti P, Conte M, et al. Minimally invasive surgery for thyroid small nodules: preliminary report. J Endocrinol Invest 1999; 22(11):849-51.

59. Miccoli P, Berti P, Materazzi G, et al. Minimally invasive video-assisted thyroidectomy: five years of experience. J Am Coll Surg 2004; 199(2):243-8.

60. Terris DJ, Gourin CG, Chin E. Minimally invasive thyroidectomy: basic and advanced techniques. Laryngoscope 2006; 116(3):350-6.

61. Ujiki MB, Sturgeon C, Denham D, et al. Minimally invasive video-assisted thyroidectomy for follicular neoplasm: is there an advantage over conventional thyroidectomy? Ann Surg Oncol 2006; 13(2):182-6.

62. Miyauchi A, Matsusaka K, Kihara M, et al: The role of ansa to recurrent laryngeal nerve anastomosis in operations for thyroid cancer. Eur J Surg 164:927-933, 1998.

63. Dackiw AP, Rotstein LE, Clark OH. Computer-assisted evoked electromyography with stimulating surgical instruments for recurrent/external laryngeal nerve identification and preservation in thyroid and parathyroid operation. Surgery 2002; 132(6):1100-6; discussion 1107-8.

64. Beldi G, Kinsbergen T, Schlumpf R. Evaluation of intraoperative recurrent nerve monitoring in thyroid surgery. World J Surg 2004; 28(6):589-91.

65. Hemmerling TM, Schmidt J, Bosert C, et al. Intraoperative monitoring of the recurrent laryngeal nerve in 151 consecutive patients undergoing thyroid surgery. Anesth Analg 2001; 93(2):396-9 , 3rd contents page.

66. Dralle H, Sekulla C, Haerting J, et al. Risk factors of paralysis and functional outcome after recurrent laryngeal nerve monitoring in thyroid surgery. Surgery 2004; 136(6):1310-22.

67. Udelsman R. Experience counts. Ann Surg 2004; 240(1):26-7.

68. Pattou F, Combemale F, Fabre S, et al: Hypocalcemia following thyroid surgery: Incidence and prediction of outcome. World J Surg 22:718-724, 1998.

69. Sedgwick CE, Cady B: Surgery of the Thyroid and Parathyroid Glands, 2nd ed. Philadelphia, WB Saunders, 1980.

70. Weller GL: Development of the thyroid, parathyroid, and thymus glands in man. Contrib Embryol Carnegie Inst Wash 24:93-142, 1933.

71. Gray SW, Skandalakis JE: Embryology for Surgeons. Philadelphia, WB Saunders, 1972.

72. Norris EH: Parathyroid glands and lateral thyroid in man: Their morphogenesis, histogenesis, topographic anatomy and prenatal growth. Contrib Embryol Carnegie Inst Wash 26:247-294, 1937.

72a. Williams ED, Toyn CE, Harach HR: The ultimobranchial gland and congenital thyroid abnormalities in man. J Pathol 159:135-141, 1989. 72b. Siraj QH, Aleem N, Inam-Ur-Rehman A, et al: The pyramidal lobe: A scintigraphic assessment. Nucl Med Commun 10:685-693, 1989.

73. Vasquez-Chavez C, Acevedo-Rivera K, Sartorius C, Espinosa-Said L: Thyroid hemiagenesis: Report of 3 cases and review of the literature. Gac Med Mex 125:395-399, 1989.

74. Khatri VP, Espinosa MH, Harada WA: Papillary adenocarcinoma in thyroid hemiagenesis. Head Neck 14:312-315, 1992.

75. Netter RA: Endocrine system and selected metabolic diseases. In Ciba Collection of Medical Illustrations. Summit, NJ, Ciba Pharmaceutical Company, 1974, p 45.

76. Buckman LT: Lingual thyroid. Laryngoscope 46:765-784, 878-897, 935-955, 1936.

77. Zink A, Rave F, Hoffmann R, Ziegler R: Papillary carcinoma in ectopic thyroid. Horm res 35:86-88, 1991.

78. Elprana D, Manni JJ, Smals AGH: Lingual thyroid. ORL J Otorhinolaryngol Relat Spec 46:147-152, 1984.

79. Defoer FY, Mahler C: Lingual thyroid in two natural brothers. J Endocrinol Invest 13:65-67, 1990.

80. Allard RHB: The thyroglossal cyst. Head Neck 5:134-146, 1982.

81. Weiss SD, Orlich CC: Primary papillary carcinoma of a thyroglossal duct cyst: Report of a case and review of the literature. Br J Surg 78:87-89, 1991.

82. Katz AD, Hachigian M: Thyroglossal duct cysts: A thirty-year experience with emphasis on occurrence in older patients. Am J Surg 155:741-744, 1988.

83. Issa MM, de Vries P: Familial occurrence of thyroglossal duct cyst. J Pediatr Surg 26:30-31, 1991.

84. Conklin WT, Davis RM, Dabb RW, Reilly CM: Hypothyroidism following removal of a “thyroglossal duct cyst.” Plast Reconstr Surg 68:930-932, 1981.

85. Helidonis E, Dokianakis G, Papazoglou G, et al: Ectopic thyroid gland in the submandibular region. J Laryngol Otol 94:219-224, 1980.

86. Stanton A, Allen-Mersh TG: Is laterally situated ectopic thyroid tissue always malignant? J R Soc Med 77:333-334, 1984.

87. Wychulis AR, Payne WS, Clagett OT, et al: Surgical treatment of mediastinal tumors. J Thorac Cardiovasc Surg 62:379, 1971.

88. Lesavoy MA, Norberg HP, Kaplan EL: Substernal goiter with superior vena caval obstruction. Surgery 77:325-329, 1975.

89. Lahey FH, Swinton NW: Intrathoracic goiter. Surg Gynecol Obstet 59:627, 1934.

90. Stagno PA, Petras RE, Hart WR: Strumal carcinoids of the ovary: An immunohistologic and ultrastructural study. Arch Pathol Lab Med 111:440-446, 1987.

91. Ramagopal E, Stanbury JB: Studies of the distribution of iodine and protein in a struma ovarii. J Clin Endocrinol Metab 25:526, 1965.

92. Kempers RD, Dockerty MB, Hoffman DL, Bartholomew LG: Struma ovarii-ascitic, hyperthyroid, and asymptomatic syndromes. Ann Intern Med 72:883, 1970.

93. March DE, Desai AG, Park CH, et al: Struma ovarii: Hyperthyroidism in a postmenopausal woman. J Nucl Med 29:263-265, 1988.

94. Thomas RD, Batty VB: Metastatic malignant struma ovarii: Two case reports. Clin Nucl Med 17:577-578, 1992.

95. Rieser GD, Ober KP, Cowan RJ, Cordell AR: Radioiodide imaging of struma cordis. Clin Nucl Med 13:421, 1988.

96. Feller KU, Mavros A, Gaertner HJ: Ectopic submandibular thyroid tissue with a coexisting active and normally located thyroid gland: case report and review of literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:618-623, 2000.

97. Mysorekar VV, Dandekar CP, Sreevathsa MR: Ectopic thyroid tissue in the parotid salivary gland. Singapore Med J 45:437-438, 2004.

98. Takahashi T, Ishikura H, Kato H, Tanabe T, Yoshiki T: Ectopic thyroid follicles in the submucosa of the duodenum. Virchows Arch A Pathol Anat Histopathol 418:547-550, 1991.

99. Shiraishi T, Imai H, Fukutome K, Watanabe M, Yatani R: Ectopic thyroid in the adrenal gland. Hum Pathol 30:105-108, 1999.

100. Ihtiyar E, Isiksoy S, Algin C, Sahin A, Erkasap S. Yasar B: Ectopic thyroid in the gallbladder: report of a case. Surg Today 33:777-780, 2003.

101. Tierti A, Damato B, Hiscott P, Vora J: Iris ectopic thyroid tissue: report of a case. Arch Ophthalmol 124:1497-1500, 2006.